?

Landry Robert E

EVP Finance CFO
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK 1585160

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
23,338
Price per Share :
$703.43
Equivalence :
$16,416,649.34

Transaction History

  • M
    Form 4
    23,338 Shares After Transaction
    Value : $8,844,635.24
    $189,490.00
    01/17/24
  • Footnotes:
    No footnote found.
  • F
    Form 4
    22,984 Shares After Transaction
    Value : $21,428,902.56
    $330,048.36
    01/17/24
  • M
    Form 4
    24,084 Shares After Transaction
    Value : $9,127,354.32
    $416,878.00
    01/23/24
  • F
    Form 4
    23,308 Shares After Transaction
    Value : $22,107,638.00
    $736,036.00
    01/23/24
  • M
    Form 4
    23,808 Shares After Transaction
    Value : $9,022,755.84
    $189,490.00
    01/24/24

Get PRO Today.

PRO unlocks 7 more insider transactions made by Landry Robert E

Start Free PRO trial Subscribe to PRO